• SimplicityBio joins EU-funded (EUROSTARS) HeartLinc Program

    SimplicityBio will apply its expertise in the frame of this €3.2 million research program, the consortium will develop an innovative in vitro diagnostic (IVD) test to assess the risk of developing heart failure (HF) after acute myocardial infarction (AMI). The test will be based on a unique profile of long noncoding RNAs (lncRNA).

  • BIO Europe Spring 2017

    SimplicityBio was selected to present in the Next Generation track at the BIO Europe Spring 2017. Drop by or schedule a 1-to-1 meeting. Barcelona, Spain. March 20-22, 2017.

  • TAmiRNA and SimplicityBio join forces to improve microRNA biomarker development

    TAmiRNA and SimplicityBio, a Swiss bioinformatics company specialized in in silico biomarker discovery, signed a partnership agreement. The aim of this partnership is to accelerate TAmiRNA´s biomarker development programs and to offer compelling biomarker development services to clients from academia and biotech industry.

  • SimplicityBio wins the 19th annual IMD Startup Competition (2016/2017)

    IMD is a top business school based in Switzerland, ranked top 3 worldwide in executive education for 5 years in a row now. SimplicityBio will collaborate with the EMBA class and travel to Silicon Valley in 2017.

  • BIO Europe Cologne 2016

    SimplicityBio was selected by Johnson & Johnson Innovation to present at BIO Europe. Drop by or schedule a 1-to-1 meeting. Cologne, Germany. November 7-9, 2016.

  • SimplicityBio has partnered with TATAA Biocenter

    Biomarker Discovery, complete solutions.
    TATAA Biocenter has partnered with SimplicityBio to offer complete solutions for biomarker discovery, signature optimization and validation. The partnership offers a complete solution comprising biomarker discovery, assay and protocol optimization, analytical validation, standardization, and clinical validation leading to robust and reliable biomarker signatures for diagnostics, prognostics and theranostics. Platforms include microarrays, qPCR, dPCR and NGS and virtually any kind of biomarkers with emphasis on mRNA, microRNA, lncRNA, DNA (SNP, CNV, methylation, cfDNA), protein and circulating tumor cells.

  • Swiss Startup Day 2016

    SimplicityBio was selected to pitch in front of investors at the Swiss Startup Day. Drop by or schedule a 1-to-1 meeting. Bern, Switzerland. October 25, 2016.

  • Poster at Global Summit on Precision Diagnosis for Prostate Cancer

    Minomic’s poster presents the Multivariate Index Analyte (MIA) Assays for Differentiating Aggressive from Non-Aggressive Prostate Cancer at the First Global Summit on Precision Diagnosis for Prostate Cancer in Boston, USA.

  • Swiss Patent Pending

    SimplicityBio has a Swiss Patent Pending on its technology and methods. For more information please contact us.

  • Client publication in Cancer Research

    Our client Cellipse has published a peer-reviewed article in AACR’s “The Journal of Cancer Research”, 1 June 2016 Edition.

  • Pioneers Festival 2016

    SimplicityBio was selected as one of the most 500 promising early-stage tech start-up and attended the Pioneers Festival, meeting with prospects and investors. May 23 - 25. Vienna, Austria.

  • BIO Europe Spring 2016

    SimplicityBio will be presenting at the BIO Europe. Drop by or schedule a 1-to-1 meeting. Stockholm, Sweden. April 4-6, 2016.

  • START Summit 2016

    Meet SimplicityBio at the START Summit. St. Gallen, Switzerland. March 18-19, 2016.

  • 3rd Austrian Biomarker Symposium 2016

    SimplicityBio will be attending the 3rd Austrian Biomarker Symposium 2016. Vienna, Austria. March 10-11, 2016.

  • 11th Annual Biomarkers Congress

    SimplicityBio is proud to be a sponsor of the 11th Annual Biomarkers Congress in Manchester, UK, February 25-26, 2016. Looking forward to meeting you there.

  • BIO-Europe 2015

    Meet SimplicityBio in Munich, Germany. November 2-4, 2015.

  • Biomarker Summit Europe 2015

    SimplicityBio is proud to be a gold sponsor of the Biomarker Summit Europe 2015 in Berlin, Germany, October 5-8, 2015. Meet us there.

  • Meeting of Experts on Biomarkers

    SimplicityBio has been invited to the Meeting of Experts on Biomarkers to Discriminate Bacterial from other Infectious Causes of Acute Fever, in Geneva, Switzerland. September 22-23 2015.

  • Nordic Life Science Days 2015

    Meet SimplicityBio at the Nordic Life Science Days in Stockholm, Sweden. September 9-10, 2015.

  • 2015 BIO International Convention

    Meet SimplicityBio in Philadelphia, PA, USA. June 15-18, 2015.

  • SimplicityBio going to Boston and New York, June 2015

    Our CEO, Miguel Barreto, and CSO, Matthew Hall, will be going to Boston and New York with the goal of business development. June, 2015.